|Home||» Products||» Active Pharmaceutical Ingredients||» MYCOPHENOLATE SODIUM|
NAME :- MYCOPHENOLATE SODIUM
IUPAC NAME :- sodium (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
CAS NO. :- 37415-62-6
FORMULA :- C17H19NaO6
SYNONYMS :- sodiummycophenolate;MYCOPHENOLATE SODIUM;mycophenolicmonosodiumsalt;mycophenolicacidmonosodiumsalt;4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-Methoxy-7-Methyl-3-oxo-5-isobenzofuranyl)-4-Methyl-,sodiuM salt
APPLICATION :- Immunosuppressant
DESCRIPTION :- Mycophenolate sodium (Myfortic® of Novartis) is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. Mycophenolate sodium is indicated for the prevention of renal transplant rejection in adults. Mycophenolate sodium has also been used for the prevention of rejection in liver, heart, and/or lung transplants in children older than two years.An immunosuppressant that has drastically decreased the incidence of acute rejection in solid transplant recipients, Mycophenolate sodium is increasingly utilized as a steroid sparing treatment in immune-mediated disorders including immunoglobulin-A nephropathy, small vessel vasculitides, and psoriasis.